Patents by Inventor Yaron Barac

Yaron Barac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treatment of renal failure
    Patent number: 8263655
    Abstract: Propargylamine, propargylamine derivatives N-propargyl-1-aminoindan and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for administration to a subject at high risk for or suffering from acute renal failure (ARF).
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: September 11, 2012
    Assignees: Technion Research and Development Foundation Ltd, Rappaport Family Institute
    Inventors: Ofer Binah, Zaid A. Abassi, Moussa B. H. Youdim, Yaron Barac
  • METHODS FOR TREATMENT OF CARDIOVASCULAR DISORDERS AND DISEASES
    Publication number: 20120095107
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-l-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Application
    Filed: December 23, 2011
    Publication date: April 19, 2012
    Applicants: RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES, TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Moussa B.H. YOUDIM, Ofer Binah, Zaid A. Abassi, Yaron Barac
  • Methods for treatment of cardiovascular disorders and diseases
    Patent number: 8097608
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: January 17, 2012
    Assignees: Technion Research and Development Foundation Ltd., Rappaport Family Institute
    Inventors: Moussa B. H. Youdim, Ofer Binah, Zaid A. Abassi, Yaron Barac
  • Methods for treatment of cardiovascular disorders and diseases
    Patent number: 8008284
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: August 30, 2011
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Moussa B. H. Youdim, Ofer Binah, Zaid A. Abassi, Yaron Barac
  • METHOD FOR PREVENTING OR ATTENUATING ANTHRACYCLINE-INDUCED CARDIOTOXICITY
    Publication number: 20080090915
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or attenuation of anthracycline-induced cardiotoxicity.
    Type: Application
    Filed: October 18, 2007
    Publication date: April 17, 2008
    Applicants: Technion Research and Development Foundation Ltd., Rappaport Family Institute for Research in the Medical Sciences
    Inventors: Moussa Youdim, Ofer Binah, Zaid Abassi, Yaron Barac
  • Methods for treatment of cardiovascular disorders and diseases
    Publication number: 20060287401
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.
    Type: Application
    Filed: June 9, 2006
    Publication date: December 21, 2006
    Applicants: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
    Inventors: Moussa Youdim, Ofer Binah, Zaid Abassi, Yaron Barac
  • Compositions and methods for treatment of cardiovascular disorders and diseases
    Publication number: 20050171210
    Abstract: Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders and diseases.
    Type: Application
    Filed: September 29, 2004
    Publication date: August 4, 2005
    Applicants: Technion Research and Development Foundation Ltd., Rappaport Family Institute For Research In The Medical Sciences
    Inventors: Moussa Youdim, Ofer Binah, Zaid Abassi, Yaron Barac